In addition, there are some other targets with high coverage that deserve further verification, such as C-type lectin-like molecule-1 (CLL-1) for acute myeloid leukemia blasts [25].The specificity of selected targets should be good enough to prevent CAR-T cells from causing serious organ damage. Here, CLEC12A is linked to acute myeloid leukemia.